Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Pharma's post-Covid run faces a reality check
Pharma's post-Covid run faces a reality check
BusinessLine

Pharma has had a strong run post-Covid. The top 10 companies, by market capitalisation, delivered 10 per cent revenue CAGR in FY21-25 and 18 per cent earnings, aided by a 400 bps PAT margin expansion, which lifted valuations. Sun Pharma's specialty…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) EVP Sells $4,374,700.00 in Stock
Royalty Pharma (NASDAQ:RPRX) EVP Sells $4,374,700.00 in Stock
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP George Lloyd sold 110,000 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $39.77, for a total value of $4,374,700.00. Following the…

marketbeat.com - Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO
Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Tema Etfs LLC lessened its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 17.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned…

marketbeat.com - BridgeBio Pharma, Inc. $BBIO Position Cut by Affinity Asset Advisors LLC
BridgeBio Pharma, Inc. $BBIO Position Cut by Affinity Asset Advisors LLC
MarketBeat

Affinity Asset Advisors LLC decreased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 50.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 150,000 shares…

marketbeat.com - NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Affinity Asset Advisors LLC
NewAmsterdam Pharma Company N.V. $NAMS Shares Sold by Affinity Asset Advisors LLC
MarketBeat

Affinity Asset Advisors LLC cut its holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 21.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…

zerohedge.com - Tyler Durden - CDC Advisory Panel Votes To End Hepatitis B Shot Recommendation For Newborns
CDC Advisory Panel Votes To End Hepatitis B Shot Recommendation For Newborns
Zero Hedge

The vaccine industrial complex is likely fuming this morning after a federal advisory panel voted to end the long-standing recommendation that all newborns receive a hepatitis B shot at birth. The vote marks a major victory for Health Secretary…

thehindubusinessline.com - Finding opportunities in an uneven market
Finding opportunities in an uneven market
BusinessLine

After two strong years in 2023 and 2024, value-oriented mutual funds have delivered a mixed bag in 2025. The Nifty50 Value 20 index, the large-cap value benchmark, has been largely flat, while the multi-cap-focused Nifty500 Value 50 has clocked a…

fool.com - Josh Kohn-Lindquist - The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
The Motley Fool

Over the last three months, the S&P 500 healthcare sector has risen 13%, compared to the broader S&P 500 index's 7% increase. However, one stock that hasn't matched its sector's returns is Halozyme Therapeutics (HALO +0.60%). Down 9% over the last…

thehindu.com - The Hindu Bureau - Congress leaders meet Puducherry Lt. Governor, seek CBI probe into fake drug manufacturing case
Congress leaders meet Puducherry Lt. Governor, seek CBI probe into fake drug manufacturing case
The Hindu

The Congress in Puducherry has requested Lieutenant Governor K. Kailashnathan to initiate administrative steps for the transfer of investigation of the fake drug manufacturing case, from the Puducherry Police to the Central Bureau of Investigation…

thehindubusinessline.com - Movers & Shakers: Stocks That Will See Action This Week
Movers & Shakers: Stocks That Will See Action This Week
BusinessLine

Aurobindo Pharma (₹1,217.45) Since January, the stock of Aurobindo Pharma has been charting a sideways trend. It has been oscillating between ₹1,020 and ₹1,250. Over the past few weeks, the stock has been hovering near the…

marketbeat.com - Teva Pharmaceutical Industries (NYSE:TEVA) Coverage Initiated by Analysts at Scotiabank
Teva Pharmaceutical Industries (NYSE:TEVA) Coverage Initiated by Analysts at Scotiabank
MarketBeat

Scotiabank began coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA - Get Free Report) in a research report issued to clients and investors on Friday. The firm set a 'sector outperform' rating and a $35.00 price target on the stock.

thehindubusinessline.com - Laurus Labs: What Should Investors Do?
Laurus Labs: What Should Investors Do?
BusinessLine

Laurus Labs has built a strong foundation on ARV generics and utilised the stable base to develop a thriving CDMO (Contract Development and Manufacturing Organisation) business. High-value business now accounts for 30 per cent of revenues in H1FY26…

marketbeat.com - Promising Growth Stocks To Consider - December 5th
Promising Growth Stocks To Consider - December 5th
MarketBeat

Prologis Stock Surges: Why the Rally May Continue Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to…

marketbeat.com - Promising Growth Stocks To Watch Today - December 6th
Promising Growth Stocks To Watch Today - December 6th
MarketBeat

Prologis Stock Surges: Why the Rally May Continue Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Canopy Growth are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are…

marketbeat.com - Prudential Financial Inc. Sells 52,530 Shares of Twist Bioscience Corporation $TWST
Prudential Financial Inc. Sells 52,530 Shares of Twist Bioscience Corporation $TWST
MarketBeat

Prudential Financial Inc. lowered its position in Twist Bioscience Corporation (NASDAQ:TWST - Free Report) by 53.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned…

Receive a Daily briefing on Pharma Industry News

Get Started